Prostate-specific antigen, also known as gamma-seminoprotein or kallikrein-3, P-30 antigen, is a glycoprotein enzyme encoded in humans by the KLK3 gene. From Wikipedia
New NHS data reveals a 25% rise in prostate cancer cases since 2019, overtaking breast cancer as the most commonly diagnosed cancer in England.